FigureĀ 2.
R vs O outcome comparison after matching. (A-B) Propensity score-matched comparison after ASCT PFS (A) and OS (B) for patients treated in the R vs O group. In this analysis, 78 and 59 responding patients in the R and O groups, respectively, were matched based on propensity score, including MRD data, resulting in 43 patients in each group. Survival curves were drawn after ASCT and maintenance initiation. (C-D) Propensity score-matched comparison of PFS (C) and OS (D) from inclusion for patients treated in the R vs O group. In this analysis, 148 and 84 patients in the R and O groups, respectively, were matched based on propensity score, resulting in 82 patients in each group. Survival curves were drawn from inclusion.

R vs O outcome comparison after matching. (A-B) Propensity score-matched comparison after ASCT PFS (A) and OS (B) for patients treated in the R vs O group. In this analysis, 78 and 59 responding patients in the R and O groups, respectively, were matched based on propensity score, including MRD data, resulting in 43 patients in each group. Survival curves were drawn after ASCT and maintenance initiation. (C-D) Propensity score-matched comparison of PFS (C) and OS (D) from inclusion for patients treated in the R vs O group. In this analysis, 148 and 84 patients in the R and O groups, respectively, were matched based on propensity score, resulting in 82 patients in each group. Survival curves were drawn from inclusion.

or Create an Account

Close Modal
Close Modal